ARCT vs BEN · rev $152.3M vs P/E 36, rev $8.77B
Arcturus Therapeutics Holdings Inc (ARCT) versus Franklin Resources Inc (BEN) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
ARCT currently screens at market cap $369.4M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Not investment advice. Open the ARCT and BEN stock pages for the full models.
Not investment advice.